You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune modulation therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)

Recruiting
  • Actinic Keratosis
  • Photodynamic Therapy
  • Celecoxib 200mg
  • Placebo
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Cryoablation
  • Cryoablation combined with PD1 Inhibitor
  • (no location specified)
Mar 28, 2023

Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

Not yet recruiting
  • Oligometastatic Prostate Cancer
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

Reduction of Peanut Reactivity and Immune Modulation With

Recruiting
  • Peanut Allergy
    • New York, New York
      Department of Genetic Medicine, Weill Cornell Medicine
    Feb 23, 2022

    Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting Trial in Lausanne (Pembrolizumab, Pembrolizumab - additional

    Active, not recruiting
    • Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
    • Lausanne, Switzerland
      Olivier Michielin
    Jan 17, 2022

    Osteoarthritis, Knee, Osteo Arthritis Knee, Knee Osteoarthritis Trial (GNSC-001, transient immune-modulation, Placebo)

    Not yet recruiting
    • Osteoarthritis, Knee
    • +9 more
    • GNSC-001
    • +2 more
    • (no location specified)
    Apr 19, 2023

    Metastatic Melanoma Trial in Pierre-Bénite (Blood and biopsy sampling)

    Completed
    • Metastatic Melanoma
    • Blood and biopsy sampling
    • Pierre-Bénite, France
      Service de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
    Dec 23, 2021

    COVID-19 Trial in Minneapolis (abatacept infusion, Placebo group)

    Not yet recruiting
    • COVID-19
    • abatacept infusion
    • Placebo group
    • Minneapolis, Minnesota
      University of Minnesota
    Apr 18, 2023

    Locally Advanced Rectal Cancer Trial (GEN-001)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • (no location specified)
    Oct 3, 2021

    Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

    Recruiting
    • Breast Cancer
    • Birmingham, Alabama
    • +3 more
    Apr 15, 2022

    Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)

    Not yet recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Vancouver, British Columbia, Canada
      St. Paul's Sinus Centre
    Oct 24, 2023

    Human Immunodeficiency Virus (HIV) Infection, Hypercholesterolemia Trial in Columbus (Soy Pretzel, Wheat Pretzel)

    Recruiting
    • Human Immunodeficiency Virus (HIV) Infection
    • Hypercholesterolemia
    • Soy Pretzel
    • Wheat Pretzel
    • Columbus, Ohio
      The Ohio State University Medical Center
    Sep 19, 2022

    Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Itacitinib
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 6, 2023

    Primary Hypertension Trial in Chongqing (External Ultrasonic Micro-bubble)

    Not yet recruiting
    • Primary Hypertension
    • External Ultrasonic Micro-bubble
    • Chongqing, Chongqing, China
      The Second Affilated Hospital of Chongqing Medical Universty
    Oct 30, 2023

    Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

    Active, not recruiting
    • Triple -Negative Breast Cancer
    • +4 more
    • Biopsy
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Aug 1, 2022

    Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

    Completed
    • Tuberculosis
    • Bergen, Norway
    • +1 more
    Apr 7, 2022

    Oral Mucositis, Pediatric Cancer Trial in Riyadh (Curcumin, Laser)

    Not yet recruiting
    • Oral Mucositis
    • Pediatric Cancer
    • Riyadh, Ar Riyadh, Saudi Arabia
      Riyadh Elm University
    Sep 15, 2023

    COVID-19, Critical Illness, Hypercytokinemia Trial in Ulm (Application of exosomes in a whole blood assay)

    Recruiting
    • COVID-19
    • +3 more
    • Application of exosomes in a whole blood assay
    • Ulm, Germany
      Ulm University Hospital, Clinic of Anesthesiology and Intensive
    Jan 17, 2022

    High-risk cSCC Treated With Surgery and Radiotherapy

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Peripheral blood sampling in order to evaluate changes in the circulating immune population
    • (no location specified)
    Feb 15, 2022

    AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

    Recruiting
    • AIDS Virus
    • Disorder of Immune Reconstitution
    • normal saline
    • Mesenchymal stem cells
    • Jinan, Shandong, China
      Shandong Public Health Clinical Center
    May 14, 2023

    Lung Cancer Stage IV Trial in Maastricht (Radiation)

    Not yet recruiting
    • Lung Cancer Stage IV
    • Radiation
    • Maastricht, Netherlands
      Maastricht Radiation Oncology (Maastro)
    Aug 29, 2023

    HNSCC Trial in Tucson (Abemaciclib)

    Recruiting
    • HNSCC
    • Tucson, Arizona
      University of Arizona
    Mar 3, 2022

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023

    Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)

    Recruiting
    • Oligorecurrent and Oligoprogressive Prostate Cancer Patients
    • Radiotherapy
    • +2 more
    • Rozzano, Milano, Italy
      Humanitas Research Hospital
    May 3, 2022